Merz Pharmaceuticals, LLC v. Taro Pharmaceuticals U.S.A., Inc.

COMPLAINT against Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 400.00, Receipt Number 0208-11789354)Document filed by Merz Pharmaceuticals, LLC, Merz North America, Inc.. (Attachments: # 1 Exhibit A - Part 1, # 2 Exhibit A - Part 2, # 3 Exhibit A - Part 3)(Coyle, Steven) (Entered: 12/31/2015)

2015-12-31

1

View

CIVIL COVER SHEET filed. (Coyle, Steven) (Entered: 12/31/2015)

2015-12-31

1

View

STATEMENT OF RELATEDNESS re: that this action be filed as related to 1:15-cv-03720-WHP. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Coyle, Steven) (Entered: 12/31/2015)

2015-12-31

1

View

REQUEST FOR ISSUANCE OF SUMMONS as to Taro Pharmaceuticals U.S.A., Inc., re: 1 Complaint,. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Coyle, Steven) (Entered: 12/31/2015)

2015-12-31

1

View

REQUEST FOR ISSUANCE OF SUMMONS as to Taro Pharmaceutical Industries Ltd., re: 1 Complaint,. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Coyle, Steven) (Entered: 12/31/2015)

2015-12-31

1

View

AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review.(Coyle, Steven) (Entered: 12/31/2015)

2015-12-31

1

View

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Merz Incorporated, Corporate Parent Merz Pharmaceuticals GmbH, Corporate Parent Merz GmbH & Co. KGaA., Corporate Parent Merz Pharma GmbH & Co. KGaA for Merz Pharmaceuticals, LLC. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Coyle, Steven) (Entered: 01/04/2016)

2016-01-04

1

View

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Merz Incorporated, Corporate Parent Merz Pharmaceuticals GmbH, Corporate Parent Merz GmbH & Co. KGaA., Corporate Parent Merz Pharma GmbH & Co. KGaA for Merz North America, Inc.. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Coyle, Steven) (Entered: 01/04/2016)

2016-01-04

1

View

Notice to Attorney Regarding Case Opening Statistical Error Correction

2016-01-04

1

No Actions

Case Opening Initial Assignment Notice

2016-01-04

1

No Actions

ELECTRONIC SUMMONS ISSUED as to Taro Pharmaceutical Industries Ltd.. (moh) (Entered: 01/05/2016)

2016-01-05

1

View

ELECTRONIC SUMMONS ISSUED as to Taro Pharmaceuticals U.S.A., Inc.. (moh) (Entered: 01/05/2016)

2016-01-05

1

View

AO 120 FORM PATENT - CASE OPENING - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a court action has been filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (moh) (Entered: 01/05/2016)

2016-01-05

1

View

MOTION for Tara Christina Stuart to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11821377. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Attachments: # 1 Exhibit 1 - Certificate of Good Standing for Attorney Tara Stuart, # 2 Text of Proposed Order)(Stuart, Tara) (Entered: 01/11/2016)

2016-01-11

1

View

Notice Regarding Pro Hac Vice Motion

2016-01-11

1

No Actions

Notice of Case Assignment/Reassignment

2016-01-11

1

No Actions

ORDER FOR ADMISSION PRO HAC VICE granting 12 Motion for Tara Christina Stuart to Appear Pro Hac Vice. (Signed by Judge William H. Pauley, III on 1/15/2016) (mro) (Entered: 01/19/2016)

2016-01-15

1

View

NOTICE OF APPEARANCE by Brian Jeffrey Robinson on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Robinson, Brian) (Entered: 02/10/2016)

2016-02-10

1

View

ANSWER to 1 Complaint,., COUNTERCLAIM against Merz North America, Inc., Merz Pharmaceuticals, LLC. Document filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc..(Robinson, Brian) (Entered: 02/10/2016)

2016-02-10

1

View

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Taro Pharmaceutical Industries, Ltd. for Taro Pharmaceuticals U.S.A., Inc.; Other Affiliate Sun Pharmaceutical Industries Ltd. for Taro Pharmaceutical Industries Ltd.. Document filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc..(Robinson, Brian) (Entered: 02/11/2016)

2016-02-11

1

View

RULE 26(f) DISCOVERY PLAN REPORT.Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Stuart, Tara) (Entered: 02/26/2016)

2016-02-26

1

View

ANSWER to 15 Counterclaim. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Coyle, Steven) (Entered: 03/02/2016)

2016-03-02

1

View

SCHEDULING ORDER: A joint status conference and initial pretrial conference is scheduled for March 24, 2016 at 10:00 a.m. So ordered. (Initial Conference set for 3/24/2016 at 10:00 AM before Judge William H. Pauley III. Status Conference set for 3/24/2016 at 10:00 AM before Judge William H. Pauley III). (Signed by Judge William H. Pauley, III on 3/4/2016) (rjm) (Entered: 03/07/2016)

2016-03-04

1

View

SCHEDULING ORDER: The joint conference and initial pretrial conference scheduled for March 24, 2016 is adjourned to April 1, 2016 at 12:00 p.m. Initial Conference set for 4/1/2016 at 12:00 PM before Judge William H. Pauley III. Status Conference set for 4/1/2016 at 12:00 PM before Judge William H. Pauley III. (Signed by Judge William H. Pauley, III on 3/9/2016) (cf) (Entered: 03/09/2016)

2016-03-09

1

View

JOINT CLAIM CONSTRUCTION STATEMENT. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Attachments: # 1 Exhibit A (Joint Disputed Claim Terms Chart))(Coyle, Steven) (Entered: 04/01/2016)

2016-04-01

1

View

SCHEDULING ORDER: Counsel having appeared for a conference on April 1, 2016, the following schedule is established on consent: Parties' Opening Claim Construction Briefs and any expert declarations re: claim construction and all intrinsic and extrinsic evidence relied upon in the Parties' Opening Claim Construction Briefs: 4/22/2016. Final Joint Pretrial Order submission: 3/17/2017. Deadline to Amend Pleadings: 8/12/2016. Fact Discovery closes: 9/23/2016. Expert Discovery closes: 2/10/2017. Claim Construction Hearing set for 7/8/2016 at 11:30 AM before Judge William H. Pauley III. Final Pretrial Conference set for 3/24/2017 at 11:00 AM before Judge William H. Pauley III. (Signed by Judge William H. Pauley, III on 4/1/2016) (mro) (Entered: 04/04/2016)

2016-04-01

1

View

NOTICE OF APPEARANCE by Brigid Morris on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Morris, Brigid) (Entered: 04/04/2016)

2016-04-04

1

View

Order

2016-04-13

1

View

Stipulation and Order

2016-04-13

1

View

1 - Terminate Deadlines AND ~Util - Case Stayed AND 1 - Terminate Hearings AND Stipulation and Order

2016-06-28

1

View

Judgment - Consent

2017-11-09

1

View

Stipulation and Order of Voluntary Dismissal

2017-11-09

1

View

AO 120 Form Patent - Case Terminated - Submitted

2017-11-13

1

View

Overview

Parties

Defendant

Taro Pharmaceutical Industries Ltd. Follow

Represented By

Plaintiff

Taro Pharmaceuticals U.S.A., Inc. Follow

Represented By

Counter Defendant

Merz North America, Inc. Follow

Represented By

Merz Pharmaceuticals, LLC Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

CIVIL COVER SHEET filed. (Coyle, Steven) (Entered: 12/31/2015)

STATEMENT OF RELATEDNESS re: that this action be filed as related to 1:15-cv-03720-WHP. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Coyle, Steven) (Entered: 12/31/2015)

REQUEST FOR ISSUANCE OF SUMMONS as to Taro Pharmaceuticals U.S.A., Inc., re: 1 Complaint,. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Coyle, Steven) (Entered: 12/31/2015)

REQUEST FOR ISSUANCE OF SUMMONS as to Taro Pharmaceutical Industries Ltd., re: 1 Complaint,. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Coyle, Steven) (Entered: 12/31/2015)

AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review.(Coyle, Steven) (Entered: 12/31/2015)

Notice to Attorney Regarding Case Opening Statistical Error Correction

Case Opening Initial Assignment Notice

ELECTRONIC SUMMONS ISSUED as to Taro Pharmaceutical Industries Ltd.. (moh) (Entered: 01/05/2016)

ELECTRONIC SUMMONS ISSUED as to Taro Pharmaceuticals U.S.A., Inc.. (moh) (Entered: 01/05/2016)

Notice Regarding Pro Hac Vice Motion

Notice of Case Assignment/Reassignment

ORDER FOR ADMISSION PRO HAC VICE granting 12 Motion for Tara Christina Stuart to Appear Pro Hac Vice. (Signed by Judge William H. Pauley, III on 1/15/2016) (mro) (Entered: 01/19/2016)

NOTICE OF APPEARANCE by Brian Jeffrey Robinson on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Robinson, Brian) (Entered: 02/10/2016)

ANSWER to 1 Complaint,., COUNTERCLAIM against Merz North America, Inc., Merz Pharmaceuticals, LLC. Document filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc..(Robinson, Brian) (Entered: 02/10/2016)

RULE 26(f) DISCOVERY PLAN REPORT.Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Stuart, Tara) (Entered: 02/26/2016)

ANSWER to 15 Counterclaim. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Coyle, Steven) (Entered: 03/02/2016)

JOINT CLAIM CONSTRUCTION STATEMENT. Document filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Attachments: # 1 Exhibit A (Joint Disputed Claim Terms Chart))(Coyle, Steven) (Entered: 04/01/2016)

NOTICE OF APPEARANCE by Brigid Morris on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Morris, Brigid) (Entered: 04/04/2016)

Order

Stipulation and Order

1 - Terminate Deadlines AND ~Util - Case Stayed AND 1 - Terminate Hearings AND Stipulation and Order

Judgment - Consent

Stipulation and Order of Voluntary Dismissal

AO 120 Form Patent - Case Terminated - Submitted

Track Case Updates

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceuticals U.S.A., Inc.

Merz North America, Inc.

Merz Pharmaceuticals, LLC